Therapeutic Goods (Exempting monographs of pharmacopoeias) Determination No. 1 of 2011 (Cth)

Case
No judgment structure available for this case.

THERAPEUTIC GOODS ACT 1989

Therapeutic Goods (Exempting monographs of pharmacopoeias) Determination No. 1 of 2011

I, Rohan Hammett, delegate of the Minister for Health and Ageing for the purposes of section 3C of the Therapeutic Goods Act 1989 (‘the Act’) and acting under subsection 3C(1) of the Act, having consulted with the Therapeutic Goods Committee, HEREBY DETERMINE that the following specified monographs of the United States Pharmacopeia‑National Formulary are exempt for the purposes of paragraph (d) of the definition of “standard” in subsection 3(1) of the Act:

Anthrax Vaccine Adsorbed
BCG Vaccine
Influenza Virus Vaccine
Measles Virus Vaccine Live
Measles, Mumps and Rubella Virus Vaccine Live
Measles and Rubella Virus Vaccines Live
Mumps Virus Vaccine Live
Poliovirus Vaccine Inactivated                   
Rabies Vaccine
Rubella Virus Vaccine Live
Smallpox Vaccine
Yellow Fever Vaccine
Diphtheria and Tetanus Toxoids Adsorbed
Tetanus and Diphtheria Toxoids Adsorbed for Adult Use
Tetanus Toxoid Adsorbed
Tetanus Toxoid
Tuberculin
Pancrelipase
Pancreatin
Rho (D) Immune Globulin
Antithrombin III Human
Antihemophilic Factor
Cryoprecipitated Antihemophilic Factor
Factor IX Complex
Hepatitis B Immune Globulin
Immune Globulin  
Pertussis Immune Globulin
Plasma Protein Fraction
Rabies Immune Globulin
Tetanus Immune Globulin
Vaccinia Immune Globulin
Varicella-Zoster Immune Globulin  

This Order commences on the day after the day it is registered on the Federal Register of Legislative Instruments.

Dated this 18th day of October 2011

(signed by)

Rohan Hammett

Delegate of the Minister for Health and Ageing

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0